Penserra Capital Management LLC Kura Oncology, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$12.22 - $19.57 $18,513 - $29,648	-1,515 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $77 - $108	5 Added 0.33%	1,515 $28,000
Q2 2021 Aug 12, 2021	BUY	$20.85 - $29.88 $312 - $448	15 Added 1.0%	1,510 $31,000
Q1 2021 May 13, 2021	BUY	$24.75 - $39.14 $4,826 - $7,632	195 Added 15.0%	1,495 $42,000
Q4 2020 Feb 12, 2021	BUY	$29.0 - $41.62 $23,780 - $34,128	820 Added 170.83%	1,300 $42,000
Q3 2020 Nov 13, 2020	BUY	$16.3 - $30.64 $7,824 - $14,707	480 New	480 $14,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $490M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.